Organigram Holdings Stock Net Asset
| OGI Stock | CAD 2.58 0.02 0.78% |
OrganiGram Holdings fundamentals help investors to digest information that contributes to OrganiGram Holdings' financial success or failures. It also enables traders to predict the movement of OrganiGram Stock. The fundamental analysis module provides a way to measure OrganiGram Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OrganiGram Holdings stock.
OrganiGram | Net Asset |
OrganiGram Holdings Company Net Asset Analysis
OrganiGram Holdings' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current OrganiGram Holdings Net Asset | 577.11 M |
Most of OrganiGram Holdings' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OrganiGram Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OrganiGram Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for OrganiGram Holdings is extremely important. It helps to project a fair market value of OrganiGram Stock properly, considering its historical fundamentals such as Net Asset. Since OrganiGram Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OrganiGram Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OrganiGram Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
OrganiGram Total Assets
Total Assets |
|
Based on the recorded statements, OrganiGram Holdings has a Net Asset of 577.11 M. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net asset for all Canada stocks is notably lower than that of the firm.
OrganiGram Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OrganiGram Holdings' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OrganiGram Holdings could also be used in its relative valuation, which is a method of valuing OrganiGram Holdings by comparing valuation metrics of similar companies.OrganiGram Holdings is currently under evaluation in net asset category among related companies.
OrganiGram Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0556 | ||||
| Profit Margin | (1.54) % | ||||
| Operating Margin | (0.44) % | ||||
| Current Valuation | 205.47 M | ||||
| Shares Outstanding | 103 M | ||||
| Shares Owned By Insiders | 27.32 % | ||||
| Shares Owned By Institutions | 8.96 % | ||||
| Number Of Shares Shorted | 1.48 M | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 1.85 X | ||||
| Revenue | 145.81 M | ||||
| Gross Profit | 31.57 M | ||||
| EBITDA | (15.21 M) | ||||
| Net Income | (229.48 M) | ||||
| Cash And Equivalents | 44.78 M | ||||
| Cash Per Share | 0.23 X | ||||
| Total Debt | 3.36 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 3.18 X | ||||
| Cash Flow From Operations | (36.21 M) | ||||
| Short Ratio | 1.32 X | ||||
| Earnings Per Share | (2.51) X | ||||
| Price To Earnings To Growth | 0.04 X | ||||
| Target Price | 3.86 | ||||
| Number Of Employees | 984 | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 265.74 M | ||||
| Total Asset | 577.11 M | ||||
| Retained Earnings | (289.93 M) | ||||
| Working Capital | 166.34 M | ||||
| Net Asset | 577.11 M |
About OrganiGram Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OrganiGram Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OrganiGram Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OrganiGram Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world |